The disease burden attributable to tobacco use in China and its provinces from 1990−2023: an analysis from the Global Burden of Disease Study 2023

Ling-Ling Yu; Fan-Shu Yan; Jin-Lei Qi; Li-Jun Wang; Mai-Geng Zhou; Peng Yin

doi:10.1016/j.mmr.2026.100041

Your Location：

Home >

Browse articles >

The disease burden attributable to tobacco use in China and its provinces from 1990−2023: an analysis from the Global Burden of Disease Study 2023

RESEARCH | Updated：2026-06-12

- The disease burden attributable to tobacco use in China and its provinces from 1990−2023: an analysis from the Global Burden of Disease Study 2023
- The disease burden attributable to tobacco use in China and its provinces from 1990−2023: an analysis from the Global Burden of Disease Study 2023
- 军事医学研究（英文） 2026年
- Affiliations：
  
  National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
- Author bio：
  
  *Peng Yin, yinpeng@ncncd.chinacdc.cn
- Funds：
- DOI：10.1016/j.mmr.2026.100041
  中图分类号：
- 收稿：2025-11-03，
  
  录用：2026-05-13，
  
  纸质出版：2026-05
- Accepted：
Scan QR Code
Ling-Ling Yu, Fan-Shu Yan, Jin-Lei Qi, 等. The disease burden attributable to tobacco use in China and its provinces from 1990−2023: an analysis from the Global Burden of Disease Study 2023[J/OL]. 军事医学研究（英文）, 2026.

Yu LL, Yan FS, Qi JL, Wang LJ, Zhou MG, Yin P. The disease burden attributable to tobacco use in China and its provinces from 1990−2023: an analysis from the Global Burden of Disease Study 2023. Mil Med Res. 2026;13(1):100041.
Ling-Ling Yu, Fan-Shu Yan, Jin-Lei Qi, 等. The disease burden attributable to tobacco use in China and its provinces from 1990−2023: an analysis from the Global Burden of Disease Study 2023[J/OL]. 军事医学研究（英文）, 2026. DOI： 10.1016/j.mmr.2026.100041.

Yu LL, Yan FS, Qi JL, Wang LJ, Zhou MG, Yin P. The disease burden attributable to tobacco use in China and its provinces from 1990−2023: an analysis from the Global Burden of Disease Study 2023. Mil Med Res. 2026;13(1):100041. DOI： 10.1016/j.mmr.2026.100041.

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

The evolving burden of heart failure in China: a 34-year subnational analysis of trends and causes from the Global Burden of Disease Study 2023

Burden of women's cancers in the group of twenty (G20) from 1990 to 2023: epidemiological trends and impact from fertility, quality of care, and survival

Establishing integrated chronic non-communicable disease management clinics to address China’s looming health burden

The national and provincial prevalence and non-fatal burdens of diabetes in China from 2005 to 2023 with projections of prevalence to 2050

Cell-free DNA in sepsis: from molecular insights to clinical management

The disease burden attributable to tobacco use in China and its provinces from 1990−2023: an analysis from the Global Burden of Disease Study 2023

The disease burden attributable to tobacco use in China and its provinces from 1990−2023: an analysis from the Global Burden of Disease Study 2023

DOI：10.1016/j.mmr.2026.100041